UNSPSC 51292908: Mirtazapine

This classification denotes an antidepressant agent with the molecular formula C17H19N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A051Q2099Q, chemically known as 1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine but generally known as mirtazapine, which bears US NIH Compound Identifier 4205. European Medicines Agency schedules Mirtazapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08996MIG.

UNSPSC 51292908 Mirtazapine is a Commodity code that nominally covers a specific antidepressant medication, but recent state and local procurement activity under this code shows a mismatch: the only recorded recent opportunity tags naloxone and drug deactivation systems, which fall outside the code's pharmaceutical scope. The source provides minimal evidence of actual mirtazapine procurement at the state or local level, and the single tagged opportunity appears to be a classification anomaly rather than a representative use of the code.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, soliciting 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The IFB required electronic submission through the county's e-Procurement Portal and included standard compliance requirements such as drug-free workplace certification, E-Verify authorization, and workers' compensation and liability insurance. The contract offered an initial two-year term with a one-year renewal option and included a three-month probationary termination clause. Given the absence of additional recent opportunities and the subject-matter mismatch, the code shows little actionable activity for vendors focused on mirtazapine supply or pharmaceutical distribution aligned with the code's nominal scope.